Leukemia Research · 2012 · 75 citations · 18 references
MedicineCell BiologyHematologyHematopathologyIron Metabolism DisordersTransfusion MedicineAnemiaIron Chelation TherapyIron DeficiencyIron HomeostasisMyelodysplastic SyndromesTransfusional Iron OverloadBone Marrow Erythroid ProgenitorsChelation In Myelodysplastic SyndromesColony-forming Unit AssaysFerritin ElevationFerritin RegulationFerritin StatusIron Overload PathophysiologyTransfusion-related Iron Overload
In patients with myelodysplastic syndromes (MDS) iron overload caused by long-term red blood cell transfusions is an important factor for comorbidity especially in low-risk MDS. In this report we present the results of a comparative study based on colony formation assays of hematopoietic cells in MDS patients with and without iron overload. We demonstrate that iron overload suppresses the proliferation of erythroid progenitors cells (BFU-E), while the myeloid compartment (CFU-GM) was not found to be affected. Even patients with slightly elevated ferritin values show an impaired proliferation capacity in comparison to patients with normal ferritin levels. Furthermore, we show that this negative impact is reversible by sufficient iron chelation therapy.
18
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
Peter L. Greenberg, Christopher Cox, Michelle M. LeBeau et al. · Blood · 1997 · 4.5K citations · Full text
Nancy L. Harris, Elaine S. Jaffe, J Diébold et al. · Journal of Clinical Oncology · 1999 · 3.3K citations
Medicine, Hematology, Pathology +17
Luca Malcovati, Matteo Giovanni Della Porta, Cristiana Pascutto et al. · Journal of Clinical Oncology · 2005 · 860 citations · Full text
Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin
JW Janssen, Michael Buschle, Mark Layton et al. · Blood · 1989 · 307 citations · Full text